Interestingly, CHQ decreased LAMP2 levels and both HIF-1α (by approximately 50%) and HIF-2α protein expression (by approximately 65%) in sarcoidosis AMs after LPS stimulation (Figure 8A–D). The gene discussed is HIF1A; the disease is sarcoidosis.